Deutsche Märkte geschlossen

Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)

NSE - NSE Echtzeitpreis. Währung in INR
Zur Watchlist hinzufügen
1.516,40-21,15 (-1,38%)
Börsenschluss: 03:29PM IST

Sun Pharmaceutical Industries Limited

Sun House
Plot No. 201 B/1 Western Express Highway Goregaon (East)
Mumbai 400063
India
91 22 4324 4324
https://www.sunpharma.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 41.000

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Dilip Shantilal ShanghviMD & Executive Director54,53MN/A1955
Mr. Kalyanasundaram SubramanianDirector of Corporate Development65,3MN/A1954
Mr. C. S. MuralidharanChief Financial Officer38,89MN/A1963
Mr. Davinder SinghExecutive Vice-President of Global OperationsN/AN/AN/A
Mr. Dheeraj Prasad Sinha BEEVP & Chief Information OfficerN/AN/A1971
Mr. Nimish DesaiHead of Investor RelationsN/AN/AN/A
Mr. Anoop DeshpandeCompany Secretary & Compliance OfficerN/AN/AN/A
Mr. Suresh Kumar RaiChief Human Resources OfficerN/AN/AN/A
Mr. Kirti Wardhaman GanorkarChief Executive Officer of India BusinessN/AN/A1967
Mr. Aalok Dilip ShanghviExecutive VP, Head of Emerging Markets, Global Generics R&D, Business Devp., and Whole Time DirectorN/AN/A1984
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in INR.

Beschreibung

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and anti retro viral medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.

Corporate Governance

Sun Pharmaceutical Industries Limiteds ISS Governance QualityScore, Stand 1. April 2024, lautet 2. Die grundlegenden Scores sind Audit: 4, Vorstand: 2, Shareholderrechte: 1, Kompensation: 6.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.